Shandong Realcan Pharmaceutical Co Ltd (002589) — Capital Reinvestment Ratio
Shandong Realcan Pharmaceutical Co Ltd (002589) has a Capital Reinvestment Ratio of 2.12x as of June 2025, meaning it reinvests 2% of its operating cash flow (CN¥24.86 Million) in capital expenditures (CN¥52.73 Million). Check tangible net worth ratio of Shandong Realcan Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Realcan Pharmaceutical Co Ltd Capital Reinvestment Ratio (2009–2025)
This chart tracks Shandong Realcan Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see Shandong Realcan Pharmaceutical Co Ltd cash flow conversion.
Annual Capital Reinvestment Ratio for Shandong Realcan Pharmaceutical Co Ltd (2009–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Realcan Pharmaceutical Co Ltd from 2009 to 2025. See Shandong Realcan Pharmaceutical Co Ltd (002589) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.95x | CN¥13.76 Million | CN¥26.82 Million | ▲ +180.4% |
| 2024 | 0.70x | CN¥160.44 Million | CN¥111.53 Million | ▼ -80.8% |
| 2023 | 3.62x | CN¥82.47 Million | CN¥298.38 Million | ▲ +1007.0% |
| 2022 | 0.33x | CN¥523.07 Million | CN¥170.96 Million | ▼ -68.6% |
| 2021 | 1.04x | CN¥442.95 Million | CN¥461.09 Million | ▼ -14.5% |
| 2020 | 1.22x | CN¥414.96 Million | CN¥505.39 Million | ▲ +172.9% |
| 2019 | 0.45x | CN¥2.09 Billion | CN¥934.87 Million | ▼ -16.5% |
| 2010 | 0.53x | CN¥70.56 Million | CN¥37.72 Million | ▲ +70.6% |
| 2009 | 0.31x | CN¥61.38 Million | CN¥19.23 Million | — |